In the case of the GHR tests, using the example of tests for BRCA1, a false-positive test could lead a consumer to experience anxiety or depression, or to have a preventive mastectomy or oophorectomy, which are invasive and serious procedures. This evidence concerns the gene GHR and major depressive disorder.